Translate page with Google

Story Publication logo October 10, 2014

Uganda: Vaccinating Schoolgirls Against HPV


Image by Sascha Garrey. Uganda, 2014.

In the U.S., the HPV vaccine and regular pap smears have almost stopped the pervasiveness of...


In 2007, a pilot project took place in two districts in Uganda to test different methods of delivering Human Papillomavirus (HPV) vaccines to girls between the ages of 10 and 15. The vaccine used—and that continues to be administered in Uganda—was Gardasil, an immunization owned by Merck that protects against HPV strains 6, 11, 16 and 18, the latter two of which are highly related to the development of cervical cancer.

The Nakasongola District of Central Uganda was one of the trial districts. Although most schoolgirls have been vaccinated consistently since the pilot project, recent financial constraints have posed serious threats to its continued success.



Three women grouped together: an elderly woman smiling, a transwoman with her arms folded, and a woman holding her headscarf with a baby strapped to her back.


Gender Equality

Gender Equality
navy halftone illustration of a female doctor with her arms crossed


Health Inequities

Health Inequities

Support our work

Your support ensures great journalism and education on underreported and systemic global issues